Target intelligence / Profile preview

Enteric nervous system (Colonic mucosal sensory nerve endings and myenteric plexus) (ENS)

Target
ENS
Molecular classification
Other
01

Overview

The colonic mucosal sensory nerve endings and the myenteric plexus are critical components of the enteric nervous system (ENS) responsible for the autonomous regulation of the gastrointestinal tract (Furness, 2012). The myenteric plexus, or Auerbach's plexus, is located between the circular and longitudinal muscle layers and primarily coordinates the motor activity of the gut, such as peristalsis and mass movements (StatPearls, 2023). Mucosal sensory nerve endings, often associated with intrinsic primary afferent neurons (IPANs), respond to mechanical and chemical stimuli from the gut lumen, transmitting signals that trigger secretomotor and vasomotor reflexes (Wood, 2008). Although this entry describes anatomical structures rather than a single molecule, these regions contain a high density of therapeutic targets, including serotonin (5-HT) and opioid receptors (Camilleri, 2009). Pharmacological intervention at these sites is used to manage functional bowel disorders like irritable bowel syndrome (IBS) and chronic constipation by modulating gut motility and visceral sensitivity (Black & Ford, 2020). Dysfunction in these neural pathways is a hallmark of various motility disorders and chronic visceral pain syndromes (Gershon, 1999).

Other names
Auerbach's plexusIntrinsic primary afferent neuronsGastrointestinal nervous systemMucosal afferentsMyenteric ganglionated plexus
02

Mechanism of action

Modulation of enteric neurotransmission and reflex arcs through activation or inhibition of specific receptors (e.g., 5-HT3, 5-HT4, and mu-opioid receptors) located on enteric neurons and sensory endings to alter motility and fluid secretion.

03

Biological functions

Signal transductionPeristalsisVisceral sensationSecretomotor regulationVasomotor control
04

Disease associations

Irritable bowel syndromeChronic idiopathic constipationInflammatory bowel diseaseIntestinal pseudo-obstructionGastroparesis
05

Safety considerations

Ischemic colitisSevere constipationCardiovascular adverse eventsBowel perforationDependency or tolerance (opioids)
06

Interacting drugs

Prucalopride

6 more in the full profile.

07

Biomarkers

Colonic transit timeVisceral pain thresholdStool consistency (Bristol Stool Scale)Calprotectin (for inflammatory context)

Beyond the preview

Go deeper on Enteric nervous system (Colonic mucosal sensory nerve endings and myenteric plexus) (ENS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteric nervous system (Colonic mucosal sensory nerve endings and myenteric plexus) (ENS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call